Expert Opinion on Emerging Drugs

Show Articles
Journal Properties
  • Formerly known as
    Emerging Drugs
  • Country
    United Kingdom
  • Language
    English
  • Number of Articles
    942
  • Abbreviation
    Expert Opin Emerg Drugs
  • ISSN
    1472-8214
  • e-ISSN
    1744-7623
  • Main Publisher
    Taylor & Francis
  • Publisher
    Informa UK Limited
  • Indian UGC
  • DOAJ (latest)
Journal Properties
  • Medicine
    Public aspects of medicine
    Toxicology
    Poisons
    Medicine
    Therapeutics
    Pharmacology
  • website
Description
Addressing the need for timely and insightful information on pharmaceutical innovation, Expert Opinion on Emerging Drugs provides expert commentary and analysis on the latest developments in drug discovery and development. It offers critical evaluations of emerging therapeutic agents, providing readers with a comprehensive overview of their potential benefits, limitations, and clinical implications. Focusing on drugs in early stages of development, the journal offers insights into their mechanisms of action, preclinical and clinical trial data, and potential impact on treatment paradigms. Expert Opinion on Emerging Drugs covers a broad range of therapeutic areas, including health sciences, medicine, pharmacology, and related disciplines. It also provides expert perspectives on regulatory issues, market trends, and the economic factors shaping the pharmaceutical landscape. Serving as an invaluable resource for pharmaceutical scientists, clinicians, and healthcare decision-makers, Expert Opinion on Emerging Drugs aims to facilitate informed decision-making and accelerate the translation of promising new drugs from bench to bedside. Discover expert opinions in the evolving drug market. Submit your manuscript today!